RETIN-A GEL Rx
Generic Name and Formulations:
Tretinoin 0.01%, 0.025%; alcohol 90%.
Valeant Pharmaceuticals, Inc
Indications for RETIN-A GEL:
Apply sparingly at bedtime to clean dry skin; adjust strength and frequency as tolerated and needed.
Not for use in eczema or sunburned skin. Avoid eyes, mouth, angles of nose, mucous membranes, sun, UV light. Discontinue if sensitivity reactions occur. Increased irritation in weather extremes. Gel: flammable. Pregnancy (Cat.C): not recommended. Nursing mothers.
Caution with concomitant topical medication, medicated or abrasive soaps/cleansers, astringents, drying agents, high-alcohol content topical products, spices. Avoid contact with peel of limes. Allow effects of benzoyl peroxide, sulfur, resorcinol, salicylic acid, other topical acne agents to subside before applying.
Local irritation, skin pain, pruritus, pharyngitis, erythema, transient symptom exacerbation or pigmentation changes, dryness, stinging, photosensitivity.
Micro 0.04%, 0.1%—20g, 45g, 50g; 0.08%—50g; Crm—20g, 45g; Gel—15g, 45g; Liq—28mL
Psychiatry Advisor Articles
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- Purpose, Questions of Social Interaction Lead Physicians to Delay Retirement
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Antidepressant Use in Pregnancy Tied to Psychiatric Disorders in Offspring?
- SSRI Use Associated With Increased Type 2 Diabetes Risk in Young Adults
- Specialty Physicians Experiencing Lack of Income Growth
- Improved Patient-Provider Communication Needed Following Urgent Care Visits
- Cardiovascular Risk Management May Slow Neurocognitive Decline in HIV
- Maintenance rTMS for Treatment-Resistant Depression